Compare · SILO vs ZGN
SILO vs ZGN
Side-by-side comparison of Silo Pharma Inc. (SILO) and Ermenegildo Zegna N.V. (ZGN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SILO and ZGN operate in Apparel (Consumer Discretionary), so they compete in similar markets.
- ZGN is the larger of the two at $3.66B, about 806.5x SILO ($4.5M).
- Over the past year, SILO is down 72.8% and ZGN is up 64.9% - ZGN leads by 137.8 points.
- SILO has been more active in the news (8 items in the past 4 weeks vs 2 for ZGN).
- ZGN has more recent analyst coverage (20 ratings vs 0 for SILO).
- Company
- Silo Pharma Inc.
- Ermenegildo Zegna N.V.
- Price
- $2.57+0.00%
- $13.65-1.59%
- Market cap
- $4.5M
- $3.66B
- 1M return
- -42.76%
- -8.48%
- 1Y return
- -72.85%
- +64.92%
- Industry
- Apparel
- Apparel
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 8
- 2
- Recent ratings
- 0
- 20
Ermenegildo Zegna N.V.
Ermenegildo Zegna N.V., together with its subsidiaries, designs, manufactures, markets, and distributes luxury menswear, footwear, leather goods, and other accessories under the Zegna and the Thom Browne brands. It provides luxury leisurewear for men; formal suits, tuxedos, shirts, blazers, formal overcoats, and accessories; leather accessories comprising shoes, bags, belts, and small leather accessories; and fragrances. The company also offers luxury womenswear and childrenswear under the Thom Browne brand, as well as provides eyewear, cufflinks and jewelry, watches, underwear, and beachwear manufactured by third parties under licenses. It serves customers through its retail stores and online channels in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company was founded in 1910 and is based in Trivero, Italy. Ermenegildo Zegna N.V. is a subsidiary of Monterubello Societa' Semplice.
Latest SILO
- Silo Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
- Silo Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Silo Pharma Inc.
- Silo Pharma Granted European Patent Covering Novel PTSD Therapy
- SEC Form EFFECT filed by Silo Pharma Inc.
- SEC Form 424B3 filed by Silo Pharma Inc.
- Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
- SEC Form S-8 filed by Silo Pharma Inc.
- SEC Form S-3 filed by Silo Pharma Inc.
Latest ZGN
- SEC Form 6-K filed by Ermenegildo Zegna N.V.
- Zegna Group downgraded by BNP Paribas Exane with a new price target
- Ermenegildo Zegna Group Records Double-Digit Revenue Growth in Q2 2026 With Accelerating DTC Momentum1
- SEC Form 6-K filed by Ermenegildo Zegna N.V.
- SEC Form 6-K filed by Ermenegildo Zegna N.V.
- SEC Form 3 filed by new insider Hamiyeh Nagi Adel
- SEC Form 6-K filed by Ermenegildo Zegna N.V.
- Ermenegildo Zegna Group Reports Voting Results of the Annual General Meeting Held on June 26, 2026
- Zegna Group downgraded by Goldman with a new price target
- Zegna Group upgraded by TD Cowen with a new price target